CardiacSense Company

"Smart Watch for Cardiac and Blood Pressure Monitoring."

CardiacSense develops noninvasive optical-based sensor technology for the medical market. The company has developed a clinically proven medical wearable device for monitoring heart arrhythmias. Its sensor monitors real-time vitals and heart-related parameters, including heart-rate variability and blood pressure.
The company’s proprietary optical solution and advanced algorithms detect and measure heart activity from different external areas of the body, comfortably and nonintrusively. The combination of CardiacSense’s hardware, algorithms, and mobile application results in a solution that provides the customer with a reliable heart monitor with low power consumption.
The CardiacSense watch is currently in the advanced stages of FDA and CE certification. CardiacSense has received ISO 13485:2016 certification for its quality management system from BSI UK.

Combating Coronavirus Pandemic:
CardiacSense's solution helps address the Coronavirus Pandemic.
Technology: COVID Treatments
Industry: HealthTech
Headquarters: Israel
Founded Date: 2009
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership